Korro Bio Stock (NASDAQ:FREQ)


ForecastOwnershipFinancialsChart

Previous Close

$0.29

52W Range

$0.18 - $5.59

50D Avg

$0.35

200D Avg

$0.64

Market Cap

$10.94M

Avg Vol (3M)

$135.07K

Beta

0.77

Div Yield

-

FREQ Company Profile


Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

46

IPO Date

Oct 03, 2019

Website

FREQ Performance


FREQ Financial Summary


Dec 22Dec 21Dec 20
Revenue-$14.07M$36.98M
Operating Income$-83.00M$-84.03M$-27.55M
Net Income$-81.58M$-84.69M$-26.51M
EBITDA$-80.62M$-81.13M$-27.63M
Basic EPS$-2.33$-2.47$-0.82
Diluted EPS$-2.33$-2.47$-0.82

Fiscal year ends in Dec 22 | Currency in USD

Peer Comparison


TickerCompany
SRRKScholar Rock Holding Corporation
OLMAOlema Pharmaceuticals, Inc.
ENOBRenovaro Biosciences Inc.
PMVPPMV Pharmaceuticals, Inc.
PRTGPortage Biotech Inc.
PRLDPrelude Therapeutics Incorporated
ONCTOncternal Therapeutics, Inc.
ABSIAbsci Corporation
PASGPassage Bio, Inc.
CCCCC4 Therapeutics, Inc.
ADVMAdverum Biotechnologies, Inc.
GLUEMonte Rosa Therapeutics, Inc.
KZRKezar Life Sciences, Inc.
STTKShattuck Labs, Inc.
ELYMEliem Therapeutics, Inc.